Old Ayala Inc Receivables Turnover Ratio (AYLA), from the fourth quarter 2022 to the fourth quarter 2021 current and historic results, rankings and more - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Old Ayala Inc   (AYLA)
 

Old Ayala Inc Accounts Receivables Turnover Ratio from the fourth quarter 2022 to the fourth quarter 2021

Quarterly Results, Trends, Rankings, Statistics


Old Ayala Inc 's ability to collect accounts receivable sequentially worsen to 2.19, indicating more challenging environment then in the third quarter 2022, but still, it is a far cry from any concerns. Old Ayala Inc 's Accounts Receivable average collection period in the Dec 31 2022 quarter, has increased to 167 days, from 54 days, in the Sep 30 2022 quarter.

If we take a look into Healthcare sector 673 other companies have achieved higher receivables turnover ratio. While total ranking has deteriorated relative to the period ending Dec 31 2022 from 4056 to 4548.

What is Receivable Turnover Ratio?
What is Old Ayala Inc Selling?


What is Receivable Turnover Ratio?




Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

AYLA Receivables Turnover Ratio (Dec 31 2022)
IV. Quarter		 (Sep 30 2022)
III. Quarter		 (Jun 30 2022)
II. Quarter		 (Mar 31 2022)
I. Quarter		 (Dec 31 2021)
IV. Quarter
Y / Y Receivable Change - -65.42 % -71.8 % 277.51 % -
Y / Y Revenue Change -90.84 % -85.44 % -95.01 % -52.98 % 14.14 %
Receivable Turnover Ratio (TTM) 2.19 6.74 7.12 6.16 9.53
AYLA's Total Ranking # 4548 # 4056 # 4428 # 4058 # 4425
Accounts Receivable average collection period days 167 54 51 59 38
Seq. Receivable Change 81.4 % -50.76 % -58.93 % - -
Seq. Revenue Change 15.38 % 139.47 % -91.7 % -60.03 % 83.36 %


Receivable Turnover Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry # 73
Healthcare Sector # 674
Overall Market # 4548

Receivable Turnover Ratio Statistics
High Average Low
0.08 0.07 0.04
(Dec 31 2020)   (Dec 31 2022)





AYLA Company Profile • Back to AYLA Efficiency Comparisons • Compare AYLA Receivables Turnover Ratio to its Competitors

Financial Statements
Old Ayala Inc 's Accounts Receivable $ 0 Millions Visit AYLA's Balance sheet
Old Ayala Inc 's Sales TTM $ 1 Millions Visit AYLA's Income Statement
Sources of AYLA's Revenues Visit AYLA's Sales by Geography

Other Accounts Receivable Turnover Ratios
Biotechnology & Pharmaceuticals Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
AYLA's Receivable Turnover Ratio versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
AYLA's Growth Rates AYLA's Roa AYLA's Inventory Turnover Ratio AYLA's Dividend Comparisons
AYLA's Profitability Ratios AYLA's Roi AYLA's Asset Turnover Ratio AYLA's Dividend Growth
AYLA's Valuation Ratios AYLA's Roe AYLA's Financial Strength Ratios AYLA's Dividend Payout Ratio



Companies with similar Receivables Turnover Ratio for the quarter ending Dec 31 2022, within Healthcare Sector Receivable Turnover Ratio Revenues for 12 Months ending Dec 31 2022 Receivable at quarter ending Dec 31 2022
Invacare Holdings Corporation  8.09 $ 741.733  Millions$ 91.630  Millions
Reflect Scientific Inc  8.09 $ 2.041  Millions$ 0.252  Millions
Shockwave Medical Inc   8.05 $ 489.733  Millions$ 60.807  Millions
Serina Therapeutics Inc   8.00 $ 0.034  Millions$ 0.004  Millions
Glaukos Corp  7.99 $ 282.862  Millions$ 35.419  Millions
Alpha Pro Tech Ltd   7.96 $ 61.981  Millions$ 7.782  Millions
Yunhong Green Cti Ltd   7.95 $ 18.048  Millions$ 2.271  Millions
Atricure Inc   7.94 $ 330.379  Millions$ 41.631  Millions
Encision Inc   7.91 $ 7.146  Millions$ 0.903  Millions
Edwards Lifesciences Corporation  7.90 $ 5,382.400  Millions$ 681.475  Millions
Qiagen N v   7.87 $ 2,081.035  Millions$ 264.531  Millions
Lite Strategy Inc   7.83 $ 62.573  Millions$ 7.988  Millions
Vapotherm Inc   7.81 $ 66.801  Millions$ 8.551  Millions
Beone Medicines Ltd   7.81 $ 1,415.921  Millions$ 181.349  Millions
Longeveron Inc   7.80 $ 1.222  Millions$ 0.157  Millions
Traws Pharma inc   7.75 $ 0.217  Millions$ 0.028  Millions
Moderna Inc   7.75 $ 19,263.000  Millions$ 2,486.000  Millions
Rvl Pharmaceuticals Plc  7.73 $ 49.721  Millions$ 6.429  Millions
The Oncology Institute Inc   7.71 $ 252.483  Millions$ 32.743  Millions
Aveanna Healthcare Holdings Inc   7.71 $ 1,787.645  Millions$ 231.851  Millions
Volitionrx Limited  7.71 $ 0.306  Millions$ 0.040  Millions
Quest Diagnostics Inc  7.69 $ 9,883.000  Millions$ 1,284.750  Millions
Dynatronics Corporation  7.66 $ 44.443  Millions$ 5.803  Millions
Marker Therapeutics inc   7.65 $ 9.014  Millions$ 1.178  Millions
Sotera Health Company  7.64 $ 1,003.687  Millions$ 131.305  Millions
Adma Biologics Inc   7.62 $ 154.080  Millions$ 20.230  Millions
Ati Physical Therapy Inc   7.61 $ 635.671  Millions$ 83.499  Millions
Lemaitre Vascular Inc   7.60 $ 161.651  Millions$ 21.266  Millions
Blueprint Medicines Corporation  7.59 $ 187.269  Millions$ 24.682  Millions
Lifeward ltd   7.57 $ 5.511  Millions$ 0.728  Millions

Date modified: 2026-06-22T16:30:30+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.